Skip to main content
NovaBay Pharmaceuticals, Inc. logo

NovaBay Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · NBY ISIN · US66987P2011 LEI · 549300D5U7PQPNEX8Q38 US Manufacturing
Filings indexed 1,026 across all filing types
Latest filing 2026-01-21 Major Shareholding Noti…
Country US United States of America
Listing US NBY

About NovaBay Pharmaceuticals, Inc.

https://novabay.com/

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Recent filings

Filing Released Lang Actions
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-01-21 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-01-21 English
424B5 Filing
Regulatory Filings
2026-01-20 English
8-K Filing
Regulatory Filings
2026-01-20 English
8-K Filing
Regulatory Filings
2026-01-16 English
Regulatory Filings 2025
Regulatory Filings
2025-11-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.